from office to om office to off label off label managing
play

From Office to om Office to Off-Label: Off-Label: Managing - PDF document

1 2 From Office to om Office to Off-Label: Off-Label: Managing Managing Ri Risk and sk and Pr Protecti otecting A ng Assets ssets Pan Panelists lists Mo Moderated by: derated by: Emily Urban, Senior Vice President, Berkley Life


  1. 1 2 From Office to om Office to Off-Label: Off-Label: Managing Managing Ri Risk and sk and Pr Protecti otecting A ng Assets ssets

  2. Pan Panelists lists Mo Moderated by: derated by: Emily Urban, Senior Vice President, Berkley Life Sciences Sp Speakers: eakers: Anne Nevard, Risk Management Executive Judith Waltz, Partner, Foley & Lardner LLP George Ward, Director of Risk Management, Corporate Compliance, Amylin Pharmaceuticals, Inc. 3 Anne Nevard, Risk Management Executive

  3. Develop loping ng a Risk a Risk Manag Management ment & & Insuranc Insurance Program Program � Determine a Company’s Risk Tolerance � Implement Risk/Insurance Programs � Communicate Risk Philosophy 5 Determining ining C Company’s R s Risk T sk Toler leranc nce Growth Stag Gr owth Stages es Start St art U Up C Company any Mid-Si Mi Size C ze Company mpany Industry Lead Ind stry Leader er Ri Risk A sk Averse se So Some Ri Risk A sk Acce ceptance ce Not Risk Aver Not R Averse � Restricted Cash � Some Free Cash Flow � Reliance on cash � Purchase insurance � Insurance limits increase while flow/reserves/bank relationships. limits=value at risk/low deductibles increase � Large self-insurance programs deductibles Exposur Exposures Increme emental Expos tal Exposures Increme emental Expos tal Exposure � Localized/regional • Global expansion/mfg • Stock volatility � Patents • Product injuries/recall • Global/large M&As � Contractual obligations • Marketing & Sales • Public Scrutiny � Suppliers/contract mfg Behaviors/Reputation • Competition (generics) � Clinical Safety • Board/Management Decisions • Gov’t regulations Stakeholders Stakehold Additional Stak Add tional Stakeholders eholders Additional Stak Add tional Stakeholders eholders • Venture Capitalists • Shareholders • Counterparties/third parties • Employees • Local Environment • Global Environment • Patients (neighbors/community)

  4. Risk Acceptance/Ri Risk Acce ptance/Risk Transfer k Transfer Reliance on Strong Loss Control Programs Catastrophic HIGH Disabling e l b a r u s n I Business Impact Significant Attritional LOW Frequency Impl Implement ementing ing Ri Risk sk Manag nagement/Insuranc ment/Insurance Programs Programs St Start Up Up Com Company any In Insu surance e usually pu lly purc rchased by sed by finance employee e employee Reliance on bro Reliance on brokers ers an and o d outside r resources Ri Risks sks • Document retention (for potential future claims) • Over/under insured (no loss history) • Misunderstanding of what is/is not insured • Mishandling of claims/limited or no loss control programs Risk Mitigation T Mitigation Techniques niques • Implement and record archive system for policies, renewal records, etc for potential future use (claim could be filed years later • Evaluate company’s risk tolerance and insure accordingly • Benchmark with like-size peers • Read policy and questions what you don’t understand • Ask internal legal staff to read policy • Establish and communicate claims handling procedures (broker will help you write) specific for your company • Contract risk management professional to conduct renewals and implement programs

  5. Impl Implement ementing ing Ri Risk sk Manag nagement/Insuranc ment/Insurance Programs Programs Mi Mid-Si Size C ze Company mpany Insur Insurance nce usual usually purc purchased hased b by staf staff i insura surance prof nce professi essional onal Reliance on bro Reliance on brokers & o ers & outsid tside resour e resources f ces for guid r guidance, ance, marketi marketing, g, mod modeling ng Ris Risks • Lack of policies and procedures • Insurance professional not known within company, “silos” • Complex insurance applications signed by officers • Focus is on insurance, not risk management • Lack of uniform metrics across company Risk Mi Miti tiga gati tion on Tech Techni niqu ques es • Write policies and procedures for such things as obtaining clinical trial insurance, claims reporting (auto, workers comp., property, product, D&O, etc.), contract insurance language templates • Build cross-functional relationships. Conduct “Show and Tell” cross-functional meetings to communicate and implement policies and procedures. • Ensure all insurance applications are reviewed by legal prior to obtaining officer’s signature • Utilize risk modeling to evaluate insurance limits/deductibles and to assess supply chain, distribution, and other risks. Possible implementation of ERM study using outside resource Impleme Impl ementin ting Ris Risk Manag Management/Insu nt/Insuranc ance Prog Programs rams Industry Le Industr Leade ader Insur Insurance nce N Negot gotiat ated b by Ri Risk M sk Manage nagement nt/Ins nsura urance ce Prof Professi ssional onal Rel Reliance on b ance on brokers & o ers & outsi tside resources f e resources for mod r modeling, m ng, marketi rketing, g, ad advi vice ce Ri Risks sks • Budget restrictions • Risk Management not integrated across company • No assigned accountability for risk mitigation • Risk program not aligned with business objectives/strategic planning Risk Mitigation T Mitigation Techniques niques • Build case studies showing financial benefit for implementing programs and obtaining headcount • Create an internal risk committee • Quantify hazard, financial, operational and strategic risks, sophisticated modeling • Implement global ERM program • Present ERM findings showing potential impact on business objectives/planning 10

  6. Communic mmunicating ng Risk Ph Risk Philosophy osophy -Top Do -Top Down Communication wn Communication • A letter from the “C Suite” -Educate em -Educate employ ployees ees • Internal contacts for risk management guidance • Reporting of incidences/claims • Internal/external behaviors • Social media use • Employees authorized to sign contracts 11 Implement Impl ementing ing Ri Risk sk Manag nagement/Insuranc ment/Insurance Programs Programs Take Aw Tak Aways ays • Risk tolerance varies, depending on company’s growth stage, loss history & cash • Focus on establishing policies and procedures during start-up phase • Build cross-functional relationships for an integrated approach • Quantify financial impact to justify implementing mitigation programs, building risk management/insurance teams. Launching company-wide initiatives • Have “C Suite” communicate corporate risk management philosophy 12

  7. George M. Ward, Director of Risk Management and Compliance, Amylin Pharmaceuticals, Inc. Insu Insuranc rance e and Ri and Risk Manag sk Management nt Tec Techniqu ques es to Tr to Treat eat Risk sks Typical Risks to a Life Science Risk Company � – Regulatory Actions � FDA Actions/Alerts/Correspondence/Statements/Warning Letters � Public Company Risks - SEC and Shareholder Activism – Compliance with GXP Standards at your labs, clinics, and plants – Strategic Relationships � Contract Manufacturing Organizations � Clinical Research Organization � Outsourced R&D � Collaboration Partnerships � Supplier Performance – Supply Chain and Distribution Risks – Trend to Virtual Companies to save expenses

  8. Risk o sk of P Potent ntial C ial Claims aims All of these can generate claims that might trigger Clinical Trial/Product Liability or D&O Insurance � Regulatory Actions can generate attorney advertising by “Bad Drug Injury Legal Center” or “Shareholder Rights � Organization” Funnel consumers, customers and shareholders to law firms who solicit cases via the internet – Risk Management Implications are the risk of product liability claims or management liability claims – against directors and officers or securities claims against the entity Product Liability Causes of Action – Strict Liability – Failure to Warn � Negligence in advising consumers or healthcare providers � Fraud – failed to advise despite knowledge of an issue or suppression of facts � Negligent Misrepresentation � Consumer Legal Remedies Act � – Off-Label Promotion or representing approved for a use when not – Promotion of products as safe and effective when not , etc. D&O Causes of Actions – Sec 10b5-1 (Insider Trading) � Sec 11 (Disgorgement of ill gotten gains) � Reg FD (Disclosure of risks to investors, at the same time!) � Insu Insuranc rance Tec e Techniqu niques to Tran es to Transf sfer the er the Risk sk Why buy insurance? � Transfer the risk � Claims are expensive! � – Product /Clinical Trial Liability Claims – D&O Claims Individual Claims � Mass tort or shareholder claims � Legal Costs, eDiscovery Costs � Liberalization of Statute of Limitation Rules � Plaintiff Attorney Networks – the finders, the minders and the grinders � Soft Market – lots of capital – the perfume of the premium can overcome the � odor of the exposure Insurer can be a source of information to control and manage the risks �

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend